Massachusetts wanted to exclude some drugs from coverage under its Medicaid program — a common negotiating tactic for private insurers looking to avoid paying for costly therapies. The Trump administration decided that the proposal goes too far, handing the pharmaceutical industry a win.
from Kaiser Health News https://ift.tt/2tSi0BB
0 comments:
Post a Comment